Prolonged disability predictors identified for low back pain

June 28, 2012
Prolonged disability predictors identified for low back pain
In patients with chronic nonspecific low back pain, impaired fasting glucose tolerance, greater pain-related disability, higher body mass index, and lower quality of life at baseline are all associated with an increased pain-related disability at one year, according to a study published online June 20 in Spine.

(HealthDay) -- In patients with chronic nonspecific low back pain (LBP), impaired fasting glucose tolerance, greater pain-related disability, higher body mass index, and lower quality of life (QoL) at baseline are all associated with an increased pain-related disability at one year, according to a study published online June 20 in Spine.

Philip Wilkens, M.Chiro., of the Oslo University Hospital in Norway, and colleagues conducted a one-year involving 250 primary care patients with chronic nonspecific LBP lasting six months or longer and degenerative lumbar osteoarthritis. Potential predictors of pain-related disability were assessed at baseline, and the correlation between potential predictors and outcome was analyzed.

The researchers found that fasting glucose levels ≥6.1 mmol/L, , and pain-related disability at baseline were associated with higher pain-related disability at one year. Similarly, QoL, as measured by EuroQoL-index and EuroQoL-visual analog scale, was also significantly associated with higher pain-related disability levels. Imaging findings, modic changes, and high-intensity zones were not shown to have any predictive ability.

"Our study findings highlight the multifactorial complexity of LBP as diverse range of predictors like impaired fasting glucose, QoL, baseline disability and obesity were significant predictors of poor disability," the authors write.

Explore further: Patients with acute low back pain have poor prognosis

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Patients with acute low back pain have poor prognosis

April 24, 2012

(HealthDay) -- Few patients with acute low back pain (LBP), with or without sciatica, declare sick leave; however, approximately half have one or more recurrences and a considerable proportion experience chronic pain six ...

Self-management has small effect on low back pain

June 5, 2012

(HealthDay) -- Compared to minimal interventions, self-management has a small effect on pain and disability in non-specific low back pain (LBP), according to a review published online May 23 in Arthritis Care & Research.

Gender, high DAS28-P index predictive of pain in early RA

May 18, 2012

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness and visual analog score) ...

Low back pain counseling strategy ups return to work

February 28, 2012

(HealthDay) -- Combining a disability evaluation with proactive counseling for workers with low back pain (LBP) results in a higher return-to-work rate, which is statistically significant at one year, according to a study ...

Pattern of disc degeneration impacts low back pain

April 12, 2012

(HealthDay) -- Contiguous, multilevel disc degeneration (CMDD) is associated with increased likelihood of low back pain (LBP) and pain severity compared with skipped level disc degeneration (SLDD), according to a study published ...

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.